Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices

Detalles Bibliográficos
Autores principales: Matanock, Almea, Lee, Grace, Gierke, Ryan, Kobayashi, Miwako, Leidner, Andrew, Pilishvili, Tamara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2019
Materias:
Full Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6871896/
https://www.ncbi.nlm.nih.gov/pubmed/31751323
http://dx.doi.org/10.15585/mmwr.mm6846a5
_version_ 1783472434219843584
author Matanock, Almea
Lee, Grace
Gierke, Ryan
Kobayashi, Miwako
Leidner, Andrew
Pilishvili, Tamara
author_facet Matanock, Almea
Lee, Grace
Gierke, Ryan
Kobayashi, Miwako
Leidner, Andrew
Pilishvili, Tamara
author_sort Matanock, Almea
collection PubMed
description
format Online
Article
Text
id pubmed-6871896
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-68718962019-12-05 Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices Matanock, Almea Lee, Grace Gierke, Ryan Kobayashi, Miwako Leidner, Andrew Pilishvili, Tamara MMWR Morb Mortal Wkly Rep Full Report Centers for Disease Control and Prevention 2019-11-22 /pmc/articles/PMC6871896/ /pubmed/31751323 http://dx.doi.org/10.15585/mmwr.mm6846a5 Text en https://creativecommons.org/licenses/by/3.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated.
spellingShingle Full Report
Matanock, Almea
Lee, Grace
Gierke, Ryan
Kobayashi, Miwako
Leidner, Andrew
Pilishvili, Tamara
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
title Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
title_full Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
title_fullStr Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
title_full_unstemmed Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
title_short Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
title_sort use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: updated recommendations of the advisory committee on immunization practices
topic Full Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6871896/
https://www.ncbi.nlm.nih.gov/pubmed/31751323
http://dx.doi.org/10.15585/mmwr.mm6846a5
work_keys_str_mv AT matanockalmea useof13valentpneumococcalconjugatevaccineand23valentpneumococcalpolysaccharidevaccineamongadultsaged65yearsupdatedrecommendationsoftheadvisorycommitteeonimmunizationpractices
AT leegrace useof13valentpneumococcalconjugatevaccineand23valentpneumococcalpolysaccharidevaccineamongadultsaged65yearsupdatedrecommendationsoftheadvisorycommitteeonimmunizationpractices
AT gierkeryan useof13valentpneumococcalconjugatevaccineand23valentpneumococcalpolysaccharidevaccineamongadultsaged65yearsupdatedrecommendationsoftheadvisorycommitteeonimmunizationpractices
AT kobayashimiwako useof13valentpneumococcalconjugatevaccineand23valentpneumococcalpolysaccharidevaccineamongadultsaged65yearsupdatedrecommendationsoftheadvisorycommitteeonimmunizationpractices
AT leidnerandrew useof13valentpneumococcalconjugatevaccineand23valentpneumococcalpolysaccharidevaccineamongadultsaged65yearsupdatedrecommendationsoftheadvisorycommitteeonimmunizationpractices
AT pilishvilitamara useof13valentpneumococcalconjugatevaccineand23valentpneumococcalpolysaccharidevaccineamongadultsaged65yearsupdatedrecommendationsoftheadvisorycommitteeonimmunizationpractices

Ejemplares similares